Deals
Pluristem Therapeutics Raises $17M at 2% Discount via Maxim Group
|
Pluristem Therapeutics (NASDAQ CM:PSTI) announced that it has raised $17,000,000 in a Registered Direct transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/177/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Pluristem Therapeutics (NASDAQ CM:PSTI) announced that it has raised $17,000,000 in a Registered Direct transaction.
Dipexium Pharmaceuticals (NASDAQ CM:DPRX) announced that it has raised $18,500,000 in a CMPO/Overnight transaction.
Veracyte (NASDAQ GM:VCYT) announced that it has secured up to $25,000,000 in an ATM (At the Market) transaction with Cantor Fitzgerald & Company.
Bio-Path Holdings (NASDAQ CM:BPTH) announced that it has secured up to $25,000,000 in an ATM (At the Market) transaction.